Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
European Journal of Pharmacology
|
October 18, 2000
Stress in schizophrenia: an integrative view
C C Gispen-de Wied
Nederlands Tijdschrift Voor Geneeskunde
|
June 19, 2003
[Schizophrenia and diabetes mellitus: not an improbable combination]
D Cohen, C C Gispen-de Wied
European Journal of Pharmacology
|
July 30, 2013
From molecule to market access: drug regulatory science as an upcoming discipline
Christine C Gispen-de Wied, Hubertus G M Leufkens
Current Psychiatry Reports
|
May 11, 2002
The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems
Christine C Gispen-de Wied, Lucres M C Jansen
Journal of Affective Disorders
|
May 1, 1992
Recall and recognition memory deficits in depression
A N Brand, J Jolles, C Gispen-de Wied
Diabetologia
|
July 30, 2005
Immunological characteristics of diabetes in schizophrenia
Dan Cohen, M R Batstra, C C Gispen-de Wied
Psychopharmacology
|
May 24, 2000
Selective impairments in the stress response in schizophrenic patients
L M Jansen, C C Gispen-de Wied, R S Kahn
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 14, 2000
Commentary on plasma levels of homovanillic acid (phVA) under influence of mental stress
B Oranje, S Bijl, A Campagne, et al.
The Journal of Nutrition, Health & Aging
|
March 21, 2009
The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)
C C Gispen-de Wied, M Kritsidima, A J A Elferink
Clinical Pharmacology and Therapeutics
|
November 29, 2007
Blunting of the cardiovascular effect of aspirin by ibuprofen: what is the evidence?
R van Westrhenen, C C Gispen-de Wied, J F F Lekkerkerker
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
European Journal of Pharmacology
|
October 18, 2000
Stress in schizophrenia: an integrative view
C C Gispen-de Wied
Nederlands Tijdschrift Voor Geneeskunde
|
June 19, 2003
[Schizophrenia and diabetes mellitus: not an improbable combination]
D Cohen, C C Gispen-de Wied
European Journal of Pharmacology
|
July 30, 2013
From molecule to market access: drug regulatory science as an upcoming discipline
Christine C Gispen-de Wied, Hubertus G M Leufkens
Current Psychiatry Reports
|
May 11, 2002
The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems
Christine C Gispen-de Wied, Lucres M C Jansen
Journal of Affective Disorders
|
May 1, 1992
Recall and recognition memory deficits in depression
A N Brand, J Jolles, C Gispen-de Wied
Diabetologia
|
July 30, 2005
Immunological characteristics of diabetes in schizophrenia
Dan Cohen, M R Batstra, C C Gispen-de Wied
Psychopharmacology
|
May 24, 2000
Selective impairments in the stress response in schizophrenic patients
L M Jansen, C C Gispen-de Wied, R S Kahn
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 14, 2000
Commentary on plasma levels of homovanillic acid (phVA) under influence of mental stress
B Oranje, S Bijl, A Campagne, et al.
The Journal of Nutrition, Health & Aging
|
March 21, 2009
The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)
C C Gispen-de Wied, M Kritsidima, A J A Elferink
Clinical Pharmacology and Therapeutics
|
November 29, 2007
Blunting of the cardiovascular effect of aspirin by ibuprofen: what is the evidence?
R van Westrhenen, C C Gispen-de Wied, J F F Lekkerkerker
Page
of 9